ADCs

Showing 3 posts of 3 posts found.

Sterling doubles ADC manufacturing capacity at Welsh facility

October 16, 2026
ADCs, Corporate, HPLC, Immunology, Infections and infestations, Oncology, manufacturing

Sterling Pharma Solutions has completed a multi-million-pound expansion of its dedicated bioconjugation facility in Deeside, Wales, doubling manufacturing capacity and …

AstraZeneca to build $1.5bn ADC facility in Singapore

May 20, 2024
Manufacturing and Production ADCs, AstraZeneca, Oncology, antibody drug conjugate, manufacturing

AstraZeneca has announced that it intends to build a $1.5bn manufacturing facility in Singapore, Singapore, for antibody drug conjugates (ADCs), …

Johnson & Johnson acquires Ambrx Biopharma for approximately $2bn

March 11, 2024
Business Services ADCs, Ambrx Biopharma, J&J, Johnson & Johnson, Oncology, acquisition

Johnson & Johnson (J&J) has announced that it has successfully completed its acquisition of Ambrx Biopharma in an all-cash merger …

The Gateway to Local Adoption Series

Latest content